Ginkgo Bioworks

Industry

  • Biotechnology
    • Drug Discovery Technologies
      • Genomics-Proteomics
      • Molecular Diversity
        • Natural Products
    • Antisense, Oligonucleotides
    • Gene Therapy, Cell Therapy
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies

Other Names/Subsidiaries

  • FGen AG
  • Project Beacon COVID-19 LLC
  • Proof Diagnostics
  • Altar
  • Ayana Bio
  • Dutch DNA
  • Circularis Biotechnologies
  • FGen
  • Patch Biosciences
  • Verb Biotics
  • YSOPIA Bioscience
  • Zymergen.
See more in Biomedtracker

Latest on Ginkgo Bioworks

In Vivo

Ginkgo Bioworks' LLM Addresses mRNA Stability

 
• By David Wild

Ginkgo Bioworks has released a large language model (LLM) to help solve a persistent drug development challenge: mRNA stability. In research published in bioRxiv, the company showed that mRNA sequen

Scrip

Stock Watch: Biotechs Sell The Family Silver

 
• By Andy Smith

Taking Stock Of Expensive Biotech I took the decision recently to take profits from much of my exposure to biotech companies in the exchange-traded funds that are based on the NASDAQ Biotech Index (NB

Scrip

Deal Watch: Bayer Ties Up With Twist On Optimization Of Antibody Discovery

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bayer, Twist Collaboration Gives German